VitaNova Life Sciences (VNOV) Cash & Equivalents Growth (1y) (2018 - 2026)
VitaNova Life Sciences (VNOV) Cash & Equivalents Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | 106.91% |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | -30.15% |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 10.03% |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 18.37% |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 8.66% |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 466.79% |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -39.13% |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 11.94% |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -30.72% |
| 10 | VitaNova Life Sciences | - | - | 316,343.00 | 188.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 188.50% |
| Oct 31, 2025 | 465.22% |
| Jul 31, 2025 | 638.96% |
| Apr 30, 2025 | 32.00% |
| Jan 31, 2025 | -49.88% |
| Apr 30, 2024 | 6,694.64% |
| Jan 31, 2024 | 7,240.02% |
| Apr 30, 2023 | -62.22% |
| Jan 31, 2023 | -70.18% |
| Oct 31, 2022 | 14.19% |
| Jan 31, 2019 | -89.73% |
| Oct 31, 2018 | -99.63% |
| Apr 30, 2018 | 2,056.59% |